Why a Risk Difference Needs a Baseline Risk
A risk difference describes an absolute contrast: the difference between two risks. An E-value, by contrast, is calculated from a risk ratio. A risk difference alone does not determine a risk ratio. To make the conversion, one must also specify the risk in the comparator group, and that baseline risk must refer to the same outcome, population, follow-up period, and estimand as the risk difference.
This matters because a fixed absolute change can represent a modest relative change when the baseline risk is high, or a much larger relative change when the baseline risk is low. The resulting E-values can therefore differ even though the risk difference is unchanged. Treating a risk difference as though it were already a risk ratio, or choosing a baseline risk from a different population, can produce a misleading sensitivity summary.
For a harmful association, \(d>0\) and \(RR>1\), so \(q=RR\). For a protective association, \(d<0\) and \(0<RR<1\), so \(q=1/RR\). The reciprocal is used to express the strength of the association in the direction away from the null; it does not change the original risk contrast. The formula presumes a finite, positive risk ratio. The zero-risk boundaries require separate attention.
Calculation and Interpretation
The calculation has two distinct stages. First, use the specified baseline risk to recover the two risks and their ratio. Then apply the risk-ratio E-value formula. The E-value is on the risk-ratio scale: under the standard E-value interpretation, it is the minimum strength of association, on the risk-ratio scale, that an unmeasured confounder would need to have with both exposure and outcome, conditional on the measured covariates, to explain away the observed association, under the relevant assumptions. It is not a probability that confounding exists, nor a guarantee that bias is absent.
Worked Example: Same Risk Difference, Lower Baseline Risk
Suppose a hypothetical analysis reports a risk difference of \(d=0.08\), or 8 percentage points, and the comparator-group baseline risk is specified as \(b=0.10\). First check the implied risks: the comparator risk is 0.10 and the exposed-group risk is \(b+d=0.10+0.08=0.18\). Both are valid probabilities.
The risk ratio is \(RR=0.18/0.10=1.80\). Because it is above 1, \(q=1.80\). Therefore, \(E=1.80+\sqrt{1.80(1.80-1)}=1.80+\sqrt{1.44}=3.00\).
For this specified baseline risk, the 8-percentage-point difference corresponds to a risk ratio of 1.80 and an E-value of 3.00. Under the standard interpretation, an unmeasured confounder would need associations of at least this magnitude with exposure and outcome, on the risk-ratio scale and conditional on measured covariates, to explain away the point estimate, subject to the assumptions behind the E-value analysis.
Worked Example: The Same Difference at a Higher Baseline Risk
Keep the hypothetical risk difference at \(d=0.08\), but now specify a comparator risk of \(b=0.40\). The implied exposed risk is \(0.40+0.08=0.48\), which is also feasible. The risk ratio is \(0.48/0.40=1.20\).
The E-value is \(E=1.20+\sqrt{1.20(1.20-1)}=1.20+\sqrt{0.24}=1.20+0.4899=1.690\), to four significant figures.
The absolute contrast is still 8 percentage points, but the relative contrast is smaller at this baseline risk. Accordingly, the E-value falls from 3.00 to about 1.690. The change does not mean that one E-value is universally correct and the other wrong: each follows from a different baseline-risk specification. The analyst must justify which baseline matches the risk difference’s estimand.
Worked Example: A Protective Risk Difference
Suppose a hypothetical estimate is \(d=-0.06\), and the comparator-group risk is \(b=0.20\). The exposed-group risk is \(b+d=0.20-0.06=0.14\). These risks are feasible and positive, so the risk ratio is \(RR=0.14/0.20=0.70\).
Because this is a protective association, use its reciprocal: \(q=1/0.70=1.4286\). Then \(E=1.4286+\sqrt{1.4286(1.4286-1)}=1.4286+\sqrt{0.6122}=1.4286+0.7824=2.211\), approximately.
Thus, for this baseline risk, the protective risk difference corresponds to an E-value of about 2.211. The direction of the original association remains protective; the reciprocal is only the orientation used to summarize its strength away from the null.
Why the Baseline Risk Changes the Result
The dependence on baseline risk follows directly from the conversion. For a fixed positive difference \(d\), \(RR=1+d/b\). Increasing \(b\) makes \(d/b\) smaller, so the risk ratio moves toward 1. For a fixed negative difference with feasible positive risks, \(RR=1+d/b\) also moves toward 1 as \(b\) increases; its reciprocal \(q\) consequently moves toward 1. The E-value increases with \(q\) for \(q\geq1\), so in either direction the E-value decreases as the relative contrast approaches the null.
This is not a separate property of the risk-difference scale: it is the consequence of converting an absolute contrast into a relative one. The conversion and E-value calculation can be shown in sequence:
Here \(p_1\) denotes the exposed-group risk. The formula also gives a short justification for why the baseline risk cannot be omitted: with \(d\) fixed, changing \(b\) changes \(d/b\), hence \(RR\), \(q\), and \(E\). For example, the two harmful-effect examples above have the same \(d\), but their risk ratios differ because their values of \(b\) differ.
Confirm that the risk difference and baseline risk concern the same outcome definition, follow-up period, population, and adjustment or standardization target.
Set the comparator risk to \(b\) and calculate the exposed risk as \(b+d\). Verify that both lie in the interval from 0 to 1.
If \(b>0\), calculate \(RR=(b+d)/b\). For \(RR<1\), use \(q=1/RR\); for \(RR\geq1\), use \(q=RR\).
Use \(E=q+\sqrt{q(q-1)}\), retain the risk difference’s direction in the explanation, and state that the result depends on the chosen baseline risk.
Assumptions, Diagnostics, and Boundary Cases
The arithmetic requires a coherent pair of risks, not merely a numerical baseline chosen for convenience. The baseline must be the comparator risk for the same target contrast. If a risk difference is adjusted or standardized, a crude baseline risk may not be compatible with it. A mismatch can make the resulting ratio a calculation between unlike quantities rather than a meaningful relative effect for the stated estimand.
The risks must also be feasible: \(0\leq b\leq1\) and \(0\leq b+d\leq1\). For a finite risk ratio, additionally require \(b>0\). For a finite reciprocal-based E-value when \(RR<1\), also require \(b+d>0\). If \(b+d=0\) while \(b>0\), then \(RR=0\) and \(1/RR\) is undefined. The usual reciprocal-based formula therefore gives no finite E-value; under a limiting convention as \(RR\) approaches zero from above, the E-value tends to infinity. If \(b=0\), the risk ratio is undefined; if both risks are zero, there is no relative risk contrast to calculate. These cases should not be silently repaired by inserting an arbitrary small number.
For a positive difference, \(b+d\leq1\) is also essential. For example, \(b=0.95\) and \(d=0.10\) imply an exposed risk of 1.05, which is impossible. A computed E-value from that pair would not be a valid sensitivity summary, even if the algebra could be carried out.
Worked Example: Checking a Zero-Risk Boundary
Consider a hypothetical protective risk difference \(d=-0.20\) with comparator risk \(b=0.20\). The implied exposed risk is \(b+d=0\), so both risks are within the probability range. The risk ratio is \(RR=0/0.20=0\). However, the protective-effect step would require \(q=1/RR=1/0\), which is undefined. Therefore the ordinary finite E-value formula cannot be applied. As positive exposed risks approach zero while \(b\) remains positive, \(RR\) approaches zero and the reciprocal-based E-value tends to infinity; report this boundary explicitly rather than calling the finite formula valid at \(RR=0\).
Useful diagnostics are simple but important: verify the signs and units of the risk difference, reconstruct both risks, check probability bounds, confirm the baseline’s target population and estimand, and independently verify whether the risk ratio is above or below 1 before orienting it. If the E-value is unexpectedly large or small, inspect the baseline-risk choice before interpreting the result. Rounding the risks too early can also move a near-zero risk to zero, creating an artificial boundary problem.
What This Summary Does and Does Not Compare
A risk difference is often useful because it expresses an absolute change in percentage points, while a risk ratio describes a relative change. The E-value is not a replacement for either measure: it summarizes sensitivity to unmeasured confounding after a risk-ratio-scale association has been specified. Reporting the risk difference, baseline risk, implied risk ratio, and E-value together makes the scale conversion transparent.
An alternative is to analyze and report the risk ratio directly when that is the target estimand. In that case, the risk-difference conversion is unnecessary. Another option is to report sensitivity results for a range of plausible baseline risks when no single baseline is clearly justified. This is more informative than presenting an arbitrary single value, but it does not remove uncertainty about which risk corresponds to the target population. A risk-difference sensitivity analysis and a risk-ratio sensitivity analysis are not automatically interchangeable: the former needs a baseline-risk specification to produce the latter’s E-value.
The E-value also does not establish that the observed association is causal, quantify the probability of residual confounding, or show that a confounder with the required strength exists. Its standard interpretation depends on the causal estimate and assumptions relevant to the analysis, including the treatment of measured covariates and the use of a risk ratio for the target association. It is a benchmark for sensitivity, not a test that validates the study design.
Common Mistakes
- Calculating an E-value directly from a risk difference. A difference of 0.08 is not a risk ratio of 1.08. Specify \(b\), calculate \(b+d\), and divide the two risks first.
- Using an unmatched baseline risk. A baseline from a different population or estimand can yield a mathematically valid but scientifically incoherent conversion. Check the target of both quantities.
- Forgetting to orient a protective ratio. When \(0<RR<1\), use \(1/RR\) in the E-value formula, while still describing the original association as protective.
- Applying the reciprocal at \(RR=0\). Division by zero is undefined. State that the finite reciprocal-based calculation does not apply; if using the limiting convention, make that explicit.
- Interpreting a larger E-value as proof of no bias. It indicates a stronger confounder association would be needed under the stated framework to explain away the estimate; it does not prove that such confounding is absent.
Check Your Understanding
Answer each question, then check the brief solutions below.
- A hypothetical risk difference is 0.05 and the comparator risk is 0.25. Find both risks, the risk ratio, and the E-value.
- Keep the risk difference at 0.05 but change the comparator risk to 0.50. Find the risk ratio and E-value. Why does it differ?
- A protective risk difference is \(-0.04\), with comparator risk 0.10. Calculate the E-value.
- For \(d=-0.10\) and \(b=0.10\), can the ordinary reciprocal-based E-value formula be used? Explain.
- Why should an adjusted risk difference not automatically be combined with a crude baseline risk?
Solutions. (1) The exposed risk is \(0.25+0.05=0.30\), so \(RR=0.30/0.25=1.20\). Thus \(E=1.20+\sqrt{0.24}=1.690\). (2) The exposed risk is 0.55 and \(RR=0.55/0.50=1.10\); \(E=1.10+\sqrt{0.11}=1.432\). The higher baseline makes the same absolute difference a smaller relative change. (3) The exposed risk is \(0.10-0.04=0.06\), so \(RR=0.60\), \(q=1/0.60=1.6667\), and \(E=1.6667+\sqrt{1.1111}=2.721\), approximately. (4) No. The exposed risk is zero, so \(RR=0\) and its reciprocal is undefined; the finite formula does not apply, although its limiting E-value tends to infinity as the ratio approaches zero from above. (5) They may refer to different target populations or estimands, so their ratio need not describe a coherent contrast. Use a baseline risk compatible with the adjusted risk difference or clearly justify the conversion.